As start-ups in the life sciences, biotech, and health tech sectors continue to react to the ever-changing business landscape brought about by the COVID-19 pandemic, founders must pivot their planning from "here and now" needs to anticipated future hurdles that must be overcome. At present, start-ups face an unprecedented array of business challenges, such as revised regulatory standards, supply chain interruptions, return-to-work policies, and obstacles in raising funds, to name a few. Accordingly, these companies must act today to prepare for what lies ahead in a post-pandemic world—and founders will need a proactive mindset as they continue to pivot their businesses and transform planning models to survive and succeed.

In this session, a panel of leading venture capital, legal, and company founder experts will address:

• How COVID-19 has and will continue to impact deal-making, including financings and sales
• Insight into investors’ decision making and due diligence processes in the current and post-pandemic environments
• Founder perspectives on raising capital via virtual meetings
• Understanding evolving regulatory standards and related considerations
• How to select the right partners for you, including legal, venture, and business factors to consider before entering into a partnership or collaboration

Tuesday, March 23, 2021
12:00 p.m. Pacific
3:00 p.m. Eastern